293b cpd has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, NJ; Pajouh, M; Poelzing, S; Rosenbaum, DS; Wilson, LD | 1 |
| Nattel, S | 1 |
2 other study(ies) available for 293b cpd and Cardiac Failure
| Article | Year |
|---|---|
IKs blockade reduces dispersion of repolarization in heart failure.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Chromans; Disease Models, Animal; Dogs; Heart Failure; Heart Ventricles; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Sulfonamides | 2005 |
Specific potassium channel blockade for arrhythmia prevention in the ionically remodeled failing heart: peril or panacea?
Topics: Animals; Arrhythmias, Cardiac; Chromans; Dogs; Heart Failure; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Sulfonamides | 2005 |